Corcept Therapeutics | CORT - Выручка от реализации

Биржевая цена
49.73
Изменение за день
3.21 6.89%
Ежемесячно
17.03%
Ежегодный
-31.67%
Q2 прогноз
45.07




Продажи Изменить Дата
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Alaunos Therapeutics USD 2K 2K 2025-03
ANI Pharmaceuticals USD 247.06M 19.25M 2025-12
Ardelyx USD 94.47M 30.74M 2026-03
Assertio Holdings USD 29.2M 1.92M 2024-09
Aurora Cannabis CAD 94.19M 3.82M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Canopy Growth CAD 74.54M 7.86M 2025-12
Corcept Therapeutics USD 164.9M 37.22M 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
J&J USD 24.1B 500M 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Merck USD 16.29B 110M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.11B 226M 2026-03
Novartis USD 13.11B 750M 2026-03
Pacira USD 177M 19.87M 2026-03
Pfizer USD 17.58B 880M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
TG Therapeutics USD 192.57M 30.87M 2025-12